Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × nilotinib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Leukemia, Myeloid, Chronic-Phase 6 Neoplasm Metastasis 4 Philadelphia Chromosome 2 Neoplasms 2 Neoplasm, Residual 2 Myeloproliferative Disorders 2 Leukemia 2 Synovitis, Pigmented Villonodular 1 Sarcoma 1 Ovarian Neoplasms 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 23 Cisplatin 20 Carboplatin 13 Paclitaxel 10 Radiotherapy 8 Radiotherapy, Intensity-Modulated 7 Docetaxel 7 cemiplimab 6 Nivolumab 6 Fluorouracil 6 Radiation 5 durvalumab 4 Drug Therapy 4 Taxes 3 Surveys and Questionnaires 3 Cetuximab 3 Blood Specimen Collection 3 toripalimab 2 atezolizumab 2 alpha-2'-deoxythioguanosine 2 Surgical Procedures, Operative 2 Standard of Care 2 Photochemotherapy 2 Petrolatum 2 Pemetrexed 2 vistusertib 1 talazoparib 1 sitravatinib 1 regorafenib 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡